TY - JOUR
T1 - Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure
AU - van Breda, G Fenna
AU - Emans, Mireille E.
AU - van der Putten, Karien
AU - Braam, Branko
AU - van Ittersum, Frans J.
AU - Kraaijenhagen, Rob J.
AU - De Borst, Martin H.
AU - Vervloet, Marc G.
AU - Gaillard, Carlo A. J. M.
N1 - M1 - 0128994
PY - 2015/6/16
Y1 - 2015/6/16
N2 - ObjectiveIn chronic kidney disease (CKD), both anemia and deregulated phosphate metabolism are common and predictive of adverse outcome. Previous studies suggest that iron status influences phosphate metabolism by modulating proteolytic cleavage of FGF23 into C-terminal fragments. Red cell distribution width (RDW) was recently identified as a strong prognostic determinant for cardiovascular morbidity and mortality, independently of iron status. We assessed whether RDW is associated with FGF23 cleaving in CKD patients with heart failure.Materials and MethodsThe associations between RDW and either intact FGF23 (iFGF23), C-terminal FGF23 (cFGF23, reflecting iFGF23 and C-terminal fragments together) and the iFGF23/cFGF23 ratio were analyzed in 52 patients with CKD (eGFR 34,9 +/- 13.9 ml/min/1.73m(2)) and chronic heart failure (CHF). Associations between RDW and FGF23 forms were studied by linear regression analysis adjusted for parameters of renal function, iron metabolism, phosphate metabolism and inflammation.ResultsMedian cFGF23 levels were 197.5 [110-408.5] RU/ml, median iFGF23 levels were 107.3 [65.1-162.2] pg/ml and median FGF23 ratio was 0.80 [0.37-0.86]. Mean RDW was 14.1 +/- 1.2%. cFGF23 and RDW were associated (beta = 1.63x10(-3), P
AB - ObjectiveIn chronic kidney disease (CKD), both anemia and deregulated phosphate metabolism are common and predictive of adverse outcome. Previous studies suggest that iron status influences phosphate metabolism by modulating proteolytic cleavage of FGF23 into C-terminal fragments. Red cell distribution width (RDW) was recently identified as a strong prognostic determinant for cardiovascular morbidity and mortality, independently of iron status. We assessed whether RDW is associated with FGF23 cleaving in CKD patients with heart failure.Materials and MethodsThe associations between RDW and either intact FGF23 (iFGF23), C-terminal FGF23 (cFGF23, reflecting iFGF23 and C-terminal fragments together) and the iFGF23/cFGF23 ratio were analyzed in 52 patients with CKD (eGFR 34,9 +/- 13.9 ml/min/1.73m(2)) and chronic heart failure (CHF). Associations between RDW and FGF23 forms were studied by linear regression analysis adjusted for parameters of renal function, iron metabolism, phosphate metabolism and inflammation.ResultsMedian cFGF23 levels were 197.5 [110-408.5] RU/ml, median iFGF23 levels were 107.3 [65.1-162.2] pg/ml and median FGF23 ratio was 0.80 [0.37-0.86]. Mean RDW was 14.1 +/- 1.2%. cFGF23 and RDW were associated (beta = 1.63x10(-3), P
KW - LEFT-VENTRICULAR HYPERTROPHY
KW - IRON-DEFICIENCY
KW - CARDIOVASCULAR MORTALITY
KW - UNSELECTED OUTPATIENTS
KW - PHOSPHATE HOMEOSTASIS
KW - HEMODIALYSIS-PATIENTS
KW - VASCULAR DYSFUNCTION
KW - PROGNOSTIC MARKER
KW - OLDER-ADULTS
KW - LARGE COHORT
U2 - 10.1371/journal.pone.0128994
DO - 10.1371/journal.pone.0128994
M3 - Article
SN - 1932-6203
VL - 10
JO - PLoS ONE [E]
JF - PLoS ONE [E]
IS - 6
ER -